FDA
approval
· 2025-09-26
FDA Approved: QVAR REDIHALER — Supplemental Application (Teva Respiratory, LLC)
Summary
FDA approved Teva's supplemental application for QVAR REDIHALER (beclomethasone dipropionate HFA), expanding the approved QVAR inhaled corticosteroid product to…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for QVAR REDIHALER (BECLOMETHASONE DIPROPIONATE HFA)